Cargando…
Attenuation of Adverse Postinfarction Left Ventricular Remodeling with Empagliflozin Enhances Mitochondria-Linked Cellular Energetics and Mitochondrial Biogenesis
Sodium–glucose cotransporter 2 (SGLT2) inhibitors such as empagliflozin are known to reduce the risk of hospitalizations related to heart failure irrespective of diabetic state. Meanwhile, adverse cardiac remodeling remains the leading cause of heart failure and death in the USA. Thus, understanding...
Autores principales: | Song, Yang, Huang, Chengqun, Sin, Jon, Germano, Juliana de F., Taylor, David J. R., Thakur, Reetu, Gottlieb, Roberta A., Mentzer, Robert M., Andres, Allen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745294/ https://www.ncbi.nlm.nih.gov/pubmed/35008865 http://dx.doi.org/10.3390/ijms23010437 |
Ejemplares similares
-
Impact of Diabetes on Postinfarction Heart Failure and Left Ventricular Remodeling
por: von Bibra, Helene, et al.
Publicado: (2011) -
Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart Failure
por: Galli, Alessio, et al.
Publicado: (2016) -
Intermittent Use of a Short-Course Glucagon-like Peptide-1 Receptor Agonist Therapy Limits Adverse Cardiac Remodeling via Parkin-dependent Mitochondrial Turnover
por: Germano, Juliana de F., et al.
Publicado: (2020) -
Decoding Postinfarction Left Ventricular Pseudoaneurysm
por: Nguyen, Emily K., et al.
Publicado: (2022) -
Paeoniflorin improves cardiac function and decreases adverse postinfarction left ventricular remodeling in a rat model of acute myocardial infarction
por: Chen, Hengwen, et al.
Publicado: (2018)